| OMBITASVIR; PARITAPREVIR; RITONAVIR | None | ||
| 12.5MG;75MG;50MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| TECHNIVIE is a fixed-dose combination of ombitasvir, a hepatitis C virus NS5A inhibitor, paritaprevir, a hepatitis C virus NS3/4A protease inhibitor, and ritonavir, a CYP3A inhibitor and is indicated in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis. | |||
|
Yes
| |||
| TECHNIVIE | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||
| *********** ********* * ****** ******** ********** | *********** ********* * ****** ******** ********** | *********** ********* * ****** ******** ********** | ***** ************ | ****-***** ********* | ****-***** ********* | ************ *** ******* *** ******** *** | ****** *** ********* **************** | ****** *** ********* **************** | ****** *** ********* **************** | ****** *** ********* **************** | ********* ** * ************** | ********* ** * ************** | ***** ********** *************** ************ | ***** ********** *************** ************ | ***** ************** ****** **** | ***** ************** ****** **** | ***** ************** ****** **** | ***** ************** ****** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|